Patents by Inventor Suezanne E. Parker

Suezanne E. Parker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY
    Publication number: 20210284974
    Abstract: The present disclosure describes compositions and methods for treating ornithine transcarbamylase (OTC) deficiency. The compositions include a lipid formulation and messenger RNA (mRNA) encoding an OTC enzyme. The lipid formulations can comprise an ionizable cationic lipid in a lipid nanoparticle encapsulating the mRNA.
    Type: Application
    Filed: March 3, 2021
    Publication date: September 16, 2021
    Inventors: Padmanabh Chivukula, Priya Prakash Karmali, Kiyoshi Tachikawa, Suezanne E. Parker, Marciano Rodriguez Sablad, Pattraranee Limphong, Yanjie Bao, Jerel Boyd Lee Vega
  • Nucleic acid pharmaceuticals-influenza matrix
    Publication number: 20040087521
    Abstract: DNA constructs encoding influenza virus gene products, capable of being expressed upon direct introduction, via injection or otherwise, into animal tissues, are novel prophylactic pharmaceuticals which can provide immune protection against infection by homologous and heterologous strains of influenza virus.
    Type: Application
    Filed: April 16, 2001
    Publication date: May 6, 2004
    Applicant: Merck & Co., Inc.
    Inventors: John J. Donnelly, Varavani J. Dwarki, Margaret A. Liu, Donna L. Montgomery, Suezanne E. Parker, John W. Shiver, Jeffrey B. Ulmer
  • Plasmids suitable for IL-2 expression
    Publication number: 20030203863
    Abstract: The present invention relates to plasmids suitable for IL-2 expression, particularly, human IL-2 expression, and related methods.
    Type: Application
    Filed: April 23, 2002
    Publication date: October 30, 2003
    Applicant: Vical Incorporated
    Inventors: Peter M. Hobart, Michal Margalith, Suezanne E. Parker, Shirin Khatibi
  • Interferon-Beta polynucleotide therapy for autoimmune and inflammatory diseases
    Publication number: 20030091544
    Abstract: The present invention relates to methods of treating an autoimmune disease or an inflammatory condition, and in particular multiple sclerosis, in a mammal comprising administering a therapeutically effective amount of a non-infectious, non-integrating polynucleotide construct encoding a &bgr; interferon or an active fragment or variant thereof, wherein said construct is not associated with transfection-facilitating viral particles, liposomal formulations, or charged lipids.
    Type: Application
    Filed: March 13, 2002
    Publication date: May 15, 2003
    Applicant: Vical Incorporated
    Inventors: Suezanne E. Parker, Holly M. Horton
  • Cancer treatment method utilizing plasmids suitable for IL-2 expression
    Patent number: 6399588
    Abstract: The present invention relates to plasmids suitable for IL-2 expression, particularly, human IL-2 expression, and related methods.
    Type: Grant
    Filed: July 28, 2000
    Date of Patent: June 4, 2002
    Assignee: Vical Incorporated
    Inventors: Peter M. Hobart, Michal Margalith, Suezanne E. Parker, Shirin Khatibi
  • Cancer treatment method utilizing plasmids suitable for IL-2 expression
    Patent number: 6147055
    Abstract: The present invention relates to plasmids suitable for IL-2 expression, particularly, human IL-2 expression, and related methods.
    Type: Grant
    Filed: March 14, 1997
    Date of Patent: November 14, 2000
    Assignee: Vical Incorporated
    Inventors: Peter M. Hobart, Michal Margalith, Suezanne E. Parker, Shirin Khatibi
  • Plasmids suitable for IL-2 expression
    Patent number: 5641665
    Abstract: The present invention relates to plasmids suitable for IL-2 expression, particularly, human IL-2 expression, and related methods.
    Type: Grant
    Filed: November 28, 1994
    Date of Patent: June 24, 1997
    Assignee: Vical Incorporated
    Inventors: Peter M. Hobart, Michal Margalith, Suezanne E. Parker, Shirin Khatibi